Showing results (1261-1270 of 2,691) with videos related to

Sort By:
Pageof 270
The Lancet. Infectious Diseases|December 4, 2025
Integrase versus protease inhibitor therapy in advanced HIV disease (LAPTOP): a multicountry, randomised, open-label, non-inferiority trialGeorg M N Behrens, Lambert Assoumou, Geoffroy Liegeon, et al.
The Lancet. Infectious Diseases|December 24, 2024
Weekly dihydroartemisinin-piperaquine versus monthly sulfadoxine-pyrimethamine for malaria chemoprevention in children with sickle cell anaemia in Uganda and Malawi (CHEMCHA): a randomised, double-blind, placebo-controlled trialRichard Idro, Thandile Nkosi-Gondwe, Robert Opoka, et al.
The Lancet. Infectious Diseases|December 20, 2024
Global impact of ten-valent and 13-valent pneumococcal conjugate vaccines on invasive pneumococcal disease in all ages (the PSERENADE project): a global surveillance analysisJulia C Bennett, Maria Deloria Knoll, Eunice W Kagucia, et al.
The Lancet. Infectious Diseases|December 19, 2024
Effectiveness of ceftazidime-avibactam versus ceftolozane-tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the USA (CACTUS): a multicentre, retrospective, observational studyRyan K Shields, Lilian M Abbo, Renee Ackley, et al.
The Lancet. Infectious Diseases|January 11, 2025
Effect of mass campaigns with full and fractional doses of pneumococcal conjugate vaccine (Pneumosil) on the reduction of nasopharyngeal pneumococcal carriage in Niger: a three-arm, open-label, cluster-randomised trialMatthew E Coldiron, Issaka Soumana, Elisabeth Baudin, et al.
The Lancet. Infectious Diseases|January 18, 2025
Effectiveness of sulfadoxine-pyrimethamine plus amodiaquine and dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in Uganda: a three-arm, open-label, non-inferiority and superiority, cluster-randomised, controlled trialAnthony Nuwa, Kevin Baker, Richard Kajubi, et al.
The Lancet. Infectious Diseases|January 20, 2025
A framework towards implementation of sequencing for antimicrobial-resistant and other health-care-associated pathogensAlison Laufer Halpin, Amy J Mathers, Timothy R Walsh, et al.
The Lancet. Infectious Diseases|February 8, 2025
Approaches to increase access to community-based infectious disease control for ethnically, racially, and religiously marginalised populations: a scoping reviewSeth W M Epling, Annika M Bjork, Lucia Martinez Cruz, et al.
The Lancet. Infectious Diseases|December 17, 2023
Long-term outcomes following hospital admission for COVID-19 versus seasonal influenza: a cohort studyYan Xie, Taeyoung Choi, Ziyad Al-Aly
The Lancet. Infectious Diseases|November 28, 2023
Use of inactivated poliovirus vaccine for poliovirus outbreak responseAnanda S Bandyopadhyay, Rocio Lopez Cavestany, Isobel M Blake, et al.
Pageof 270